Literature DB >> 32215927

Hepatic artery infusion pumps.

Cornelius A Thiels1, Michael I D'Angelica1.   

Abstract

The preferential blood supply from the hepatic artery to liver tumors allows for the regional delivery of chemotherapy, commonly referred to as hepatic artery infusion chemotherapy via a subcutaneous pump. Hepatic artery infusion chemotherapy has been demonstrated to improve overall survival in select patients with colorectal liver metastasis and is a promising treatment for unresectable intrahepatic cholangiocarcinoma. This review focuses on the technical aspects of hepatic artery infusion pump placement.
© 2020 Wiley Periodicals, Inc.

Entities:  

Keywords:  colorectal neoplasms; hepatic artery infusion chemotherapy; liver neoplasms; pump; techniques

Mesh：

Substances：

Year:  2020        PMID： 32215927      PMCID： PMC9014308          DOI： 10.1002/jso.25913

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN： 0022-4790            Impact factor:   2.885


  37 in total

1.  Unresectable intrahepatic cholangiocarcinoma: Systemic plus hepatic arterial infusion chemotherapy is associated with longer survival in comparison with systemic chemotherapy alone.

Authors:  Ioannis T Konstantinidis; Bas Groot Koerkamp; Richard K G Do; Mithat Gönen; Yuman Fong; Peter J Allen; Michael I D'Angelica; T Peter Kingham; Ronald P DeMatteo; David S Klimstra; Nancy E Kemeny; William R Jarnagin
Journal:  Cancer       Date:  2015-12-22       Impact factor: 6.860

2.  Cancer statistics, 2019.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2019-01-08       Impact factor: 508.702

3.  Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer.

Authors:  N Kemeny; Y Huang; A M Cohen; W Shi; J A Conti; M F Brennan; J R Bertino; A D Turnbull; D Sullivan; J Stockman; L H Blumgart; Y Fong
Journal:  N Engl J Med       Date:  1999-12-30       Impact factor: 91.245

4.  Haematogenous metastatic patterns in colonic carcinoma: an analysis of 1541 necropsies.

Authors:  L Weiss; E Grundmann; J Torhorst; F Hartveit; I Moberg; M Eder; C M Fenoglio-Preiser; J Napier; C H Horne; M J Lopez
Journal:  J Pathol       Date:  1986-11       Impact factor: 7.996

Review 5.  Role of Hepatic Artery Infusion Chemotherapy in Treatment of Initially Unresectable Colorectal Liver Metastases: A Review.

Authors:  Jashodeep Datta; Raja R Narayan; Nancy E Kemeny; Michael I D'Angelica
Journal:  JAMA Surg       Date:  2019-08-01       Impact factor: 14.766

6.  Robotic hepatic arterial infusion pump placement.

Authors:  Motaz Qadan; Michael I D'Angelica; Nancy E Kemeny; Andrea Cercek; T Peter Kingham
Journal:  HPB (Oxford)       Date:  2017-01-26       Impact factor: 3.647

7.  Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481).

Authors:  Nancy E Kemeny; Donna Niedzwiecki; Donna R Hollis; Heinz-Josef Lenz; Robert S Warren; Michelle J Naughton; Jane C Weeks; Elin R Sigurdson; James E Herndon; Chunfeng Zhang; Robert J Mayer
Journal:  J Clin Oncol       Date:  2006-02-27       Impact factor: 44.544

Review 8.  Clinical pharmacology of hepatic arterial chemotherapy.

Authors:  W D Ensminger; J W Gyves
Journal:  Semin Oncol       Date:  1983-06       Impact factor: 4.929

9.  Response rates of hepatic arterial infusion pump therapy in patients with metastatic colorectal cancer liver metastases refractory to all standard chemotherapies.

Authors:  Andrea Cercek; Taryn M Boucher; Jill S Gluskin; Ariel Aguiló; Joanne F Chou; Louise C Connell; Marinela Capanu; Diane Reidy-Lagunes; Michael D'Angelica; Nancy E Kemeny
Journal:  J Surg Oncol       Date:  2016-08-26       Impact factor: 3.454

10.  Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial.

Authors:  Andrea Cercek; Thomas Boerner; Benjamin R Tan; Joanne F Chou; Mithat Gönen; Taryn M Boucher; Haley F Hauser; Richard K G Do; Maeve A Lowery; James J Harding; Anna M Varghese; Diane Reidy-Lagunes; Leonard Saltz; Nikolaus Schultz; T Peter Kingham; Michael I D'Angelica; Ronald P DeMatteo; Jeffrey A Drebin; Peter J Allen; Vinod P Balachandran; Kian-Huat Lim; Francisco Sanchez-Vega; Neeta Vachharajani; Maria B Majella Doyle; Ryan C Fields; William G Hawkins; Steven M Strasberg; William C Chapman; Luis A Diaz; Nancy E Kemeny; William R Jarnagin
Journal:  JAMA Oncol       Date:  2020-01-01       Impact factor: 31.777
View more
  2 in total

1.  A Comprehensive Review of Management of Colorectal Liver Mets in the Current Era.

Authors:  Hassan Aziz; Zubair Ahmed; Yi Lee; Gavin Drumm; Muhammad Wasif Saif
Journal:  Cancer Med J       Date:  2021-11-29

Review 2.  Local Treatments in the Unresectable Patient with Colorectal Cancer Metastasis: A Review from the Point of View of the Medical Oncologist.

Authors:  Javier Torres-Jiménez; Jorge Esteban-Villarrubia; Reyes Ferreiro-Monteagudo; Alfredo Carrato
Journal:  Cancers (Basel)       Date:  2021-11-25       Impact factor: 6.639
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.